Navigation Links
Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients

logic toxicities, including acneform rash, skin drying and fissuring, and inflammatory and infectious sequelae (eg, blepharitis, cheilitis, cellulitis, cyst) were reported. In 208 patients receiving ERBITUX + RT, acneform rash was reported in 87% (17% severe) as compared to 10% in 212 patients treated with radiation therapy alone (1% severe). In patients receiving ERBITUX alone, 76% (N=103) experienced acneform rash (1% severe). In patients with mCRC, acneform rash was reported in 89% (686/774) of all treated patients, and was severe in 11% (84/774). Subsequent to the development of severe dermatologic toxicities, complications including S. aureus sepsis and abscesses requiring incision and drainage were reported. Sun exposure may exacerbate these effects. A related nail disorder, occurring in 12% (0.4% Grade 3) of patients, was characterized as a paronychial inflammation.

The safety of ERBITUX in combination with radiation therapy and cisplatin has not been established. Death and serious cardiotoxicity were observed in a single-am trial with ERBITUX, delayed, accelerated (concomitant boost) fractionation radiation therapy, and cisplatin (100 mg/m2) conducted in patients with locally advanced squamous cell carcinoma of the head and neck. Two of 21 patients died, one as a result of pneumonia and one of an unknown cause. Four patients discontinued treatment due to adverse events. Two of these discontinuations were due to cardiac events (myocardial infarction in one patient and arrhythmia, diminished cardiac output, and hypotension in the other patient).

The incidence of hypomagnesemia (both overall and severe [NCI CTC Grades 3 & 4]) was increased in patients receiving ERBITUX alone or in combination with chemotherapy as compared to those receiving best supportive care or chemotherapy alone based on ongoing, controlled clinical trials in 244 patients. Approximately one-half of these patients receiving ERBITUX experienced hypomagnesemia and 10-15% expe
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/4/2015)... 2015 Microbrush International, a leading developer, producer ... restorative procedures, today announced the acquisition of DentiSmart ... sectional matrix system used in dental restorative procedures. ... opportunity to add DentiSmart to our growing portfolio ... VP and General Manager of Microbrush. "DentiSmart,s products ...
(Date:5/4/2015)... May 4, 2015 DePuy Synthes CMF* today ... the first commercially available biosynthesized dural replacement derived from ... a part of the DePuy Synthes Companies of Johnson ... membrane that covers and protects the brain and spinal ... allow surgeons to access the brain. A dural graft, ...
(Date:5/4/2015)... Former NASA scientist Tamim Hamid ... he discussed Theradome™, the first portable and wearable OTC ... shows firsthand how, via laser technology, Theradome™ offers individuals ... will not require surgery or medication.  ... of the hair follicle, which is where the stem ...
Breaking Medicine Technology:Microbrush International Announces Acquisition of DentiSmart 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 3FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 METTLER ... The Importance of Data Integrity in a GXP ... as guest presenter. This webinar will be presented ... GMT). , Data integrity is a critical component ... to regulatory agencies. However, in recent years an ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Now in ... IPC clinical leaders who have made outstanding contributions to ... they serve, both in acute and post-acute care settings. ... Year, Post-Acute Provider of the Year, Advanced Practice Clinician ... Specialist Provider of the Year. Recipients are selected by ...
(Date:5/4/2015)... May 04, 2015 EY today announced ... as a finalist for the EY Entrepreneur Of The ... The awards program recognizes entrepreneurs who demonstrate excellence and ... and personal commitment to their businesses and communities. ... panel of independent judges. Award winners will be ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 ... is now offering a more comfortable and attractive alternative ... restoration of choice for those who have lost teeth. ... can feel insecure or slip at the worst possible ... eats or talks. They can also painfully pinch or ...
(Date:5/4/2015)... SC (PRWEB) May 04, 2015 Ticket Down ... at the Colonial Life Arena in Columbia, South Carolina. ... the continuation of his “Out There” tour which originally kicked ... long tour is North America and the legendary performer recently ... at the Wells Fargo Arena on June 21st, in Charlottesville, ...
Breaking Medicine News(10 mins):Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2
... 15 Mark Hollis, the President of,MacPractice, Inc. announced ... of MacPractice,s portfolio of products. Mr. Hollis said,that "his ... with an,established partner to provide clients tight integration for ... McMahon, President and CEO of Parallel Software stated that ...
... Slimmer waists. Healthier blood,pressure. Less risk for ... the,wish list for most adults. Here,s more on ... reality., Listen to this report from Apple ... Registered journalists can access video, audio, text, ...
... IRVINE, Calif., April 15 Edwards Lifesciences,Corporation (NYSE: ... to,treat advanced cardiovascular disease, plans to announce its operating,results ... market closes on,Tuesday, April 22, 2008 and will host ... discuss its results., To participate in the conference ...
... natural resources, CAMP HILL, Pa., April 15 ... But Highmark Blue Shield recognizes the impact of,our business ... and is in the process of implementing sustainable, eco-friendly ... include a variety of facility management,community and business projects ...
... of the cervix, prostate and breast, among others , , ... causes food poisoning may be the next weapon in the ... women worldwide. , A new trial shows that a live ... some benefit in 15 women with advanced cervical cancer. , ...
... Avalere Health today reminded,consumers to pay close ... plan, including on which "tier" or group their,medications ... database show that an overwhelming majority of Medicare ... some of the most expensive drugs,in newly created ...
Cached Medicine News:Health News:Parallel Software Announces Integrated Credit Card Processing for MacPractice MD, DDS, DC and 20/20 2Health News:Edwards Lifesciences to Host Earnings Conference Call on April 22, 2008 2Health News:Highmark Blue Shield Announces Sustainable, Eco-Friendly and Green Strategy 2Health News:Highmark Blue Shield Announces Sustainable, Eco-Friendly and Green Strategy 3Health News:Highmark Blue Shield Announces Sustainable, Eco-Friendly and Green Strategy 4Health News:Experimental Cancer Vaccines Show Promise 2Health News:Avalere Health Data Finds Four-Tier System Growing Among Medicare Part D Plans 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: